Endo International



Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 59.6M 5.52M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Ligand Pharmaceuticals USD 20.9M 61.44M 2025-06
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.88B 290M 2025-09
Pacira USD 49.36M 4.96M 2025-09
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Supernus Pharmaceuticals USD 41.9M 432K 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Xeris Pharmaceuticals USD 17.42M 8.83M 2025-09
Zoetis USD 1.04B 87M 2025-09


Endo International - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.